3-[2-(2-bromo-5-isopropoxy-4-methoxyphenyl)ethyl]-7-isopropoxy-8-methoxy-1-[4-methoxy-5-(methoxymethoxy)-2-methylphenyl][1]benzopyrano[3,4-b]pyrrol-4(3H)-one | 1454845-01-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 3-[2-(2-bromo-5-isopropoxy-4-methoxyphenyl)ethyl]-7-isopropoxy-8-methoxy-1-[4-methoxy-5-(methoxymethoxy)-2-methylphenyl][1]benzopyrano[3,4-b]pyrrol-4(3H)-one
• 英文别名: 3-[2-(2-Bromo-4-methoxy-5-propan-2-yloxyphenyl)ethyl]-8-methoxy-1-[4-methoxy-5-(methoxymethoxy)-2-methylphenyl]-7-propan-2-yloxychromeno[3,4-b]pyrrol-4-one；3-[2-(2-bromo-4-methoxy-5-propan-2-yloxyphenyl)ethyl]-8-methoxy-1-[4-methoxy-5-(methoxymethoxy)-2-methylphenyl]-7-propan-2-yloxychromeno[3,4-b]pyrrol-4-one
• CAS: 1454845-01-2
• 化学式: C₃₇H₄₂BrNO₉
• 分子量: 724.646
• InChiKey: BHPMBTHQRCRZGJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.1
• 重原子数：
  48
• 可旋转键数：
  14
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  95.8
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  3-[2-(2-bromo-5-isopropoxy-4-methoxyphenyl)ethyl]-7-isopropoxy-8-methoxy-1-[4-methoxy-5-(methoxymethoxy)-2-methylphenyl][1]benzopyrano[3,4-b]pyrrol-4(3H)-one 在 四(三苯基膦)钯 、 potassium carbonate 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 乙醇 、 正己烷 、 二氯甲烷 、 N,N-二甲基乙酰胺 为溶剂， 反应 44.0h， 生成 (aS)-3,11-diisopropoxy-2,12-dimethoxy-14-[4-methoxy-5-(methoxymethoxy)-2-methylphenyl]-6H-[1]benzopyrano[4',3':4,5]pyrrolo[2,1-a]-isoquinolin-6-one
  参考文献：
  名称：

  Synthesis, Resolution, and Biological Evaluation of Atropisomeric (aR)- and (aS)-16-Methyllamellarins N: Unique Effects of the Axial Chirality on the Selectivity of Protein Kinases Inhibition

  摘要：

  The total synthesis of the optically active (aR)- and (aS)-16-methyllamellarins N (3a and 3b) was achieved via resolution on HPLC chiral stationary phase. The kinase inhibitory activities of both enantiomers were evaluated on eight protein Icinases relevant to cancer and neurodegenerative diseases (CDKI/cyclin B, CDK2/cyclin A, CDK5/p25, GSK-3 alpha/beta, PIM1, DYRK1A, CLIO, and CK1). Isomer (aR)-3b exhibited potent but nonselective inhibition on all protein kinases except CK1, while (aS)-3a selectively inhibited only GSK-3 alpha/beta, PIM1, and DYRKIA. The different inhibition profiles of (aS)-3a and (aR)-3b were elucidated by docking simulation studies. Although parental lamellarin N (2) inhibited the action of topoisomerase I, both (aS)-3a and (aR)-3b showed no inhibition of this enzyme. The phenotypic scytotoxic activities of 2, (aS)-3a, and (aR)-3b on three cancer cell lines (HeLa, SH-SYSY, and IMR32) changed according to their topoisomerase I and protein kinase inhibitory activities.

  DOI：

  10.1021/jm400719y
• 作为产物：
  描述：

  2-甲氧基-4-甲基苯酚 在 N-溴代丁二酰亚胺(NBS) 、 四(三苯基膦)钯 、 叔丁基锂 、 N,N-二异丙基乙胺 、 cesium fluoride 、 silver(l) oxide 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 71.0h， 生成 3-[2-(2-bromo-5-isopropoxy-4-methoxyphenyl)ethyl]-7-isopropoxy-8-methoxy-1-[4-methoxy-5-(methoxymethoxy)-2-methylphenyl][1]benzopyrano[3,4-b]pyrrol-4(3H)-one
  参考文献：
  名称：

  Synthesis, Resolution, and Biological Evaluation of Atropisomeric (aR)- and (aS)-16-Methyllamellarins N: Unique Effects of the Axial Chirality on the Selectivity of Protein Kinases Inhibition

  摘要：

  The total synthesis of the optically active (aR)- and (aS)-16-methyllamellarins N (3a and 3b) was achieved via resolution on HPLC chiral stationary phase. The kinase inhibitory activities of both enantiomers were evaluated on eight protein Icinases relevant to cancer and neurodegenerative diseases (CDKI/cyclin B, CDK2/cyclin A, CDK5/p25, GSK-3 alpha/beta, PIM1, DYRK1A, CLIO, and CK1). Isomer (aR)-3b exhibited potent but nonselective inhibition on all protein kinases except CK1, while (aS)-3a selectively inhibited only GSK-3 alpha/beta, PIM1, and DYRKIA. The different inhibition profiles of (aS)-3a and (aR)-3b were elucidated by docking simulation studies. Although parental lamellarin N (2) inhibited the action of topoisomerase I, both (aS)-3a and (aR)-3b showed no inhibition of this enzyme. The phenotypic scytotoxic activities of 2, (aS)-3a, and (aR)-3b on three cancer cell lines (HeLa, SH-SYSY, and IMR32) changed according to their topoisomerase I and protein kinase inhibitory activities.

  DOI：

  10.1021/jm400719y

文献信息

• Synthesis, Resolution, and Biological Evaluation of Atropisomeric (a<i>R</i>)- and (a<i>S</i>)-16-Methyllamellarins N: Unique Effects of the Axial Chirality on the Selectivity of Protein Kinases Inhibition
  作者：Kenyu Yoshida、Ryosuke Itoyama、Masashi Yamahira、Junji Tanaka、Nadège Loaëc、Olivier Lozach、Emilie Durieu、Tsutomu Fukuda、Fumito Ishibashi、Laurent Meijer、Masatomo Iwao

  DOI：10.1021/jm400719y

  日期：2013.9.26

  The total synthesis of the optically active (aR)- and (aS)-16-methyllamellarins N (3a and 3b) was achieved via resolution on HPLC chiral stationary phase. The kinase inhibitory activities of both enantiomers were evaluated on eight protein Icinases relevant to cancer and neurodegenerative diseases (CDKI/cyclin B, CDK2/cyclin A, CDK5/p25, GSK-3 alpha/beta, PIM1, DYRK1A, CLIO, and CK1). Isomer (aR)-3b exhibited potent but nonselective inhibition on all protein kinases except CK1, while (aS)-3a selectively inhibited only GSK-3 alpha/beta, PIM1, and DYRKIA. The different inhibition profiles of (aS)-3a and (aR)-3b were elucidated by docking simulation studies. Although parental lamellarin N (2) inhibited the action of topoisomerase I, both (aS)-3a and (aR)-3b showed no inhibition of this enzyme. The phenotypic scytotoxic activities of 2, (aS)-3a, and (aR)-3b on three cancer cell lines (HeLa, SH-SYSY, and IMR32) changed according to their topoisomerase I and protein kinase inhibitory activities.